Evidence that Igf2 down-regulation in postnatal tissues and up-regulation in malignancies is driven by transcription factor E2f3
about
Unraveling the message: insights into comparative genomics of the naked mole-ratCell injury, retrodifferentiation and the cancer treatment paradoxA targetable GATA2-IGF2 axis confers aggressiveness in lethal prostate cancerEZH1 and EZH2 promote skeletal growth by repressing inhibitors of chondrocyte proliferation and hypertrophyExpression levels of insulin-like growth factors 1 and 2 in head and neck squamous cell carcinoma.HDAC 1/4-mediated silencing of microRNA-200b promotes chemoresistance in human lung adenocarcinoma cells.ECR-MAPK regulation in liver early development.Adaptations to a subterranean environment and longevity revealed by the analysis of mole rat genomes.Evidence That Up-Regulation of MicroRNA-29 Contributes to Postnatal Body Growth DecelerationFunctional evolution of IGF2:IGF2R domain 11 binding generates novel structural interactions and a specific IGF2 antagonistDefective prolactin signaling impairs pancreatic β-cell development during the perinatal period.Essential role of insulin-like growth factor 2 in resistance to histone deacetylase inhibitors.Type I insulin-like growth factor receptor signaling in hematological malignancies.Insulin-like growth factor 2 axis supports the serum-independent growth of malignant rhabdoid tumor and is activated by microenvironment stress.Insulin-like growth factor 2 is a key mitogen driving liver repopulation in mice.Insulin-like growth factor 2: a poor prognostic biomarker linked to racial disparity in women with uterine carcinosarcoma.Tissue-specific and mosaic imprinting defects underlie opposite congenital growth disorders in mice.
P2860
Q26745908-474FE9B0-33F9-4F61-B47A-03CC836C04CFQ26783201-B69934F3-B222-449A-BC1C-8A8105D5113FQ27853127-4A1E099F-9A14-4FE6-8EDB-457314BF6C2EQ33815652-1568DA17-FA13-4043-8E5B-602BE7F2A512Q33850252-7D3D59A2-EAD6-43F8-9CC8-6FECCFBB000EQ33917640-85B30B8D-CFCA-4BBF-A8C6-A11F8399CBB4Q34798968-17E208F8-855C-41B3-A2FD-B5E2CEF13B14Q35150992-F1660B1F-FAB9-428C-B7A1-D669FAA70E0FQ35661315-8EB977D9-71BB-4270-8A9A-B2D1AB92E24EQ36930975-11C2F510-03B1-427B-968D-AD885EE33E16Q37341979-58759CCF-BF79-4C28-AF45-1A7FDCF4B617Q37348159-95F4BDB5-F37D-45AA-8606-2DDF2369C1F9Q37702186-47E99321-0DFB-4F32-AE89-7AFF1AC16E5DQ38682244-640A6990-6A27-4296-8F65-AE69F1F02FEFQ48216169-69A21EFD-3B84-4A12-A51F-4747BE16152DQ49890391-BEFB537A-9DE0-447D-B774-21924E7A126AQ50422325-0D634147-DF67-4A23-B3D3-2551545833B5
P2860
Evidence that Igf2 down-regulation in postnatal tissues and up-regulation in malignancies is driven by transcription factor E2f3
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Evidence that Igf2 down-regula ...... n by transcription factor E2f3
@ast
Evidence that Igf2 down-regula ...... n by transcription factor E2f3
@en
type
label
Evidence that Igf2 down-regula ...... n by transcription factor E2f3
@ast
Evidence that Igf2 down-regula ...... n by transcription factor E2f3
@en
prefLabel
Evidence that Igf2 down-regula ...... n by transcription factor E2f3
@ast
Evidence that Igf2 down-regula ...... n by transcription factor E2f3
@en
P2860
P356
P1476
Evidence that Igf2 down-regula ...... n by transcription factor E2f3
@en
P2093
Jeffrey Baron
Julian C Lui
P2860
P304
P356
10.1073/PNAS.1219079110
P407
P577
2013-03-25T00:00:00Z